Table 3.
Laboratoristic parameters (baseline vs. 1 year follow‐up)
| Variables | Baseline | 1 year FU | P |
|---|---|---|---|
| sGlucose (mg/dL) | 112.86 ± 48.14 | 119.57 ± 38.70 | 0.779 |
| AST (mg/dL) | 19.57 ± 5.26 | 19.86 ± 7.40 | 0.935 |
| ALT (mg/dL) | 16.71 ± 10.92 | 19.14 ± 14.30 | 0.727 |
| LDL (mg/dL) | 90.2 ± 37.80 | 82.8 ± 50.59 | 0.799 |
| Haemoglobin (g/dL) | 11.83 ± 1.53 | 12.58 ± 2.98 | 0.568 |
| sUA (mg/dL) | 10.15 ± 2.68 | 7.09 ± 2.29 | 0.048 |
| eGFR (mL/min/1.73 m2) | 51.41 ± 29.80 | 28.11 ± 15.64 | 0.083 |
| sUrea (mg/dL) | 89.57 ± 32.64 | 135.14 ± 75.61 | 0.169 |
| sCreatinine (mg/dL) | 1.31 ± 0.86 | 1.57 ± 0.79 | 0.568 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; eGFR, estimated glomerular filtration rate; FU, follow‐up; LDL, low‐density lipoprotein; sCreatinine, serum creatinine; sGlucose, serum glucose; sUA, serum uric acid; sUrea, serum urea.
We have reported in bold the statistically significant P‐value.